As we begin a shortened trading week for Thanksgiving, three major pharmaceutical companies have now announced success trials of COVID-19 vaccines. AstraZeneca followed Pfizer and Moderna in bringing forward new tools in the fight against the pandemic. Equity futures have responded positively to begin the week, and all major US indices are now solidly positive for the year with the NASDAQ significantly higher. New COVID-19 cases have moved significantly higher this fall, but so far the rise in fatalities has not kept pace thus far, implying that our healthcare system may be more adept at combating the disease. While we are still dealing with the societal and economic impact of the pandemic, it seems as though there is light at the end of the tunnel.
Year-to-Date COVID-19 Cases & Deaths
Key Economic Releases This Week
Asset Class Returns
Prices & Interest Rates
Past performance may not be representative of future results. All investments are subject to loss. Forecasts regarding the market or economy are subject to a wide range of possible outcomes. The views presented in this market update may prove to be inaccurate for a variety of factors. These views are as of the date listed above and are subject to change based on changes in fundamental economic or market-related data. Please contact your Financial Advisor in order to complete an updated risk assessment to ensure that your investment allocation is appropriate.